NO974934D0 - 10,13,15-trioksatrisyklo[9.2.1.19.6]pentadekanonderivater, fremgangsmåte for deres fremstilling og legemidler som inneholder disse forbindelsene - Google Patents

10,13,15-trioksatrisyklo[9.2.1.19.6]pentadekanonderivater, fremgangsmåte for deres fremstilling og legemidler som inneholder disse forbindelsene

Info

Publication number
NO974934D0
NO974934D0 NO974934A NO974934A NO974934D0 NO 974934 D0 NO974934 D0 NO 974934D0 NO 974934 A NO974934 A NO 974934A NO 974934 A NO974934 A NO 974934A NO 974934 D0 NO974934 D0 NO 974934D0
Authority
NO
Norway
Prior art keywords
trioxatricyclo
pentadecanone
derivatives
compounds
preparation
Prior art date
Application number
NO974934A
Other languages
English (en)
Other versions
NO974934L (no
NO308362B1 (no
Inventor
Dagmar Hoeltje
Ulf Preuschoff
Christian Eeckhout
Emil Finner
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of NO974934D0 publication Critical patent/NO974934D0/no
Publication of NO974934L publication Critical patent/NO974934L/no
Publication of NO308362B1 publication Critical patent/NO308362B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
NO974934A 1996-10-24 1997-10-24 10,13,15-trioksatrisyklo[9.2.1.19.6]pentadekanonderivater, fremgangsmÕte for deres fremstilling og legemidler som inneholder disse forbindelsene NO308362B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19644195A DE19644195A1 (de) 1996-10-24 1996-10-24 10,13,15-Trioxatricyclo[9.2.1.1.·9·.·6·]-pentadecanon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (3)

Publication Number Publication Date
NO974934D0 true NO974934D0 (no) 1997-10-24
NO974934L NO974934L (no) 1998-04-27
NO308362B1 NO308362B1 (no) 2000-09-04

Family

ID=7809858

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974934A NO308362B1 (no) 1996-10-24 1997-10-24 10,13,15-trioksatrisyklo[9.2.1.19.6]pentadekanonderivater, fremgangsmÕte for deres fremstilling og legemidler som inneholder disse forbindelsene

Country Status (27)

Country Link
US (1) US5912235A (no)
EP (1) EP0838469B1 (no)
JP (1) JP4175682B2 (no)
KR (1) KR100466495B1 (no)
CN (1) CN1093133C (no)
AR (1) AR009809A1 (no)
AT (1) ATE211745T1 (no)
AU (1) AU726092B2 (no)
BR (2) BR9705143A (no)
CA (1) CA2219311C (no)
CZ (1) CZ291768B6 (no)
DE (2) DE19644195A1 (no)
DK (1) DK0838469T3 (no)
DZ (1) DZ2322A1 (no)
ES (1) ES2170318T3 (no)
HK (1) HK1010885A1 (no)
HU (1) HU222540B1 (no)
IL (1) IL121969A (no)
MX (1) MX9707974A (no)
NO (1) NO308362B1 (no)
NZ (1) NZ328979A (no)
PL (1) PL184693B1 (no)
PT (1) PT838469E (no)
RU (1) RU2181727C2 (no)
SK (1) SK283114B6 (no)
UA (1) UA44310C2 (no)
ZA (1) ZA979059B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998023629A1 (fr) * 1996-11-26 1998-06-04 Chugai Seiyaku Kabushiki Kaisha Composes de macrolides comportant une chaine a 13 elements, medicament les contenant et leur procede de preparation
DE60027015T2 (de) * 2000-08-17 2006-10-05 The Kitasato Institute Pseudoerythromycin-derivate
JP2003007917A (ja) * 2001-06-19 2003-01-10 Sanyo Electric Co Ltd 回路装置の製造方法
US6986882B2 (en) * 2002-01-17 2006-01-17 Astrazeneca Ab Therapy for functional dyspepsia
JP4928261B2 (ja) 2003-06-18 2012-05-09 トランザイム・ファーマ・インコーポレイテッド モチリン受容体の大環状拮抗薬
GB0611907D0 (en) 2006-06-15 2006-07-26 Glaxo Group Ltd Compounds
JP2009501199A (ja) 2005-07-12 2009-01-15 グラクソ グループ リミテッド Ｇｐｒ３８アゴニストとしてのピペラジンヘテロアリール誘導体
NZ565062A (en) 2005-07-26 2011-02-25 Glaxo Group Ltd Benzylpiperazine derivates and their use in treating conditions mediated by GPR38 receptors
EP1960414A4 (en) * 2005-12-08 2008-12-17 Pfizer METHOD FOR DEMETHYLATING THE 3-DIMETHYLAMINOGRUPPE OF ERYTHROMYCIN COMPOUNDS
ES2344484T3 (es) 2006-06-28 2010-08-27 Glaxo Group Limited Derivados de piperazinilo utiles en el tratamiento de enfermedades mediadas por el receptor gpr38.
EP2431380A3 (en) 2006-09-11 2013-07-03 Tranzyme Pharma, Inc. Macrocyclic antagonist of the motilin receptor for treatment of gastrointestinal dysmotility disorders
CA2750699C (en) 2009-02-27 2015-12-29 Raqualia Pharma Inc. Oxyindole derivatives with motilin receptor agonistic activity
TWI662967B (zh) * 2013-03-25 2019-06-21 日商志瑞亞新藥工業股份有限公司 食後期之胃運動亢進劑

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3725385A (en) * 1970-11-02 1973-04-03 Abbott Lab Process for the demethylation of 3-amino macrolides
US5106961A (en) * 1987-05-26 1992-04-21 Eli Lilly And Company Erythromycin ring-contracted derivatives
US4920102A (en) * 1988-04-18 1990-04-24 Eli Lilly And Company Method for treating gastrointestinal disorders
DE4200145A1 (de) * 1992-01-07 1993-07-08 Kali Chemie Pharma Gmbh 7,10-epoxy-oxacyclododecan-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
AR009809A1 (es) 2000-05-03
HUP9701660A2 (hu) 1998-05-28
PL184693B1 (pl) 2002-12-31
BR9705157A (pt) 1999-09-28
SK141997A3 (en) 1998-05-06
CN1093133C (zh) 2002-10-23
PL322802A1 (en) 1998-04-27
CZ310697A3 (cs) 1998-06-17
NZ328979A (en) 1998-10-28
NO974934L (no) 1998-04-27
CA2219311A1 (en) 1998-04-24
CA2219311C (en) 2007-09-04
CZ291768B6 (cs) 2003-05-14
JPH10130297A (ja) 1998-05-19
NO308362B1 (no) 2000-09-04
MX9707974A (es) 1998-04-30
DE59705964D1 (de) 2002-02-14
SK283114B6 (sk) 2003-02-04
JP4175682B2 (ja) 2008-11-05
DE19644195A1 (de) 1998-04-30
EP0838469A1 (de) 1998-04-29
PT838469E (pt) 2002-05-31
BR9705143A (pt) 2000-12-12
HUP9701660A3 (en) 1998-08-28
ZA979059B (en) 1998-05-07
EP0838469B1 (de) 2002-01-09
HU9701660D0 (en) 1997-12-29
RU2181727C2 (ru) 2002-04-27
HU222540B1 (hu) 2003-08-28
DK0838469T3 (da) 2002-03-18
ATE211745T1 (de) 2002-01-15
DZ2322A1 (fr) 2002-12-28
CN1186808A (zh) 1998-07-08
US5912235A (en) 1999-06-15
AU726092B2 (en) 2000-11-02
KR19980032626A (ko) 1998-07-25
KR100466495B1 (ko) 2005-05-27
ES2170318T3 (es) 2002-08-01
IL121969A0 (en) 1998-03-10
IL121969A (en) 2000-06-29
UA44310C2 (uk) 2002-02-15
AU4278897A (en) 1998-04-30
HK1010885A1 (en) 1999-07-02

Similar Documents

Publication Publication Date Title
NO972881D0 (no) Piperazinderivater, legemidler som inneholder disse, anvendelse derav og fremgangsmåte for deres fremstilling
NO991815D0 (no) Oksadiazoler, fremgangsmÕter for deres fremstilling og deres anvendelse som medikamenter
DK1112251T3 (da) Azetidinderivater, deres fremstilling og medikamenter indeholdende disse derivater
NO20001409D0 (no) Karboksamidotiazolderivater, fremgangsmåte for fremstilling derav og farmasøytiske blandinger
EE04375B1 (et) Modifitseeritud aminohapped, neid ühendeid sisaldavad ravimid ja nende valmistamise meetod
NO20032733L (no) Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene og deres anvendelse
CY2369B1 (en) Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same.
NO307459B1 (no) Piperazinderivater, samt farmasøytiske preparater inneholdende slike
CY2013003I2 (el) Φωσφονοκεφεμικα παραγωγα, διαδικασια για την παρασκευη τους, και χρηση αυτων
NO984080L (no) Nye arylglycinamid-derivater, fremgangsmÕte for fremstilling derav og blandinger som inneholder disse forbindelser
NO975987D0 (no) 4-Fenylaminotiazol-derivater, fremgangsmåte for fremstilling av disse og farmasöytiske blandinger inneholdende nevnte derivater
DK0729956T3 (da) Benzothi9phenforbindelser, emllemprodukter, præparater og fremgangsmåder
EE9800265A (et) Erütromütsiini derivaadid, nende valmistamismeetod ja kasutamine ravimitena
NO932120D0 (no) Bifenylderivater, legemidler inneholdende disse, og fremgangsmaate for deres fremstilling
HUP0102292A3 (en) Substituted thiazolidinedione derivative, process for its preparation and its pharmaceutical use
NO974934D0 (no) 10,13,15-trioksatrisyklo[9.2.1.19.6]pentadekanonderivater, fremgangsmåte for deres fremstilling og legemidler som inneholder disse forbindelsene
CU22890A3 (es) Nuevo proceso de preparacion de derivados de fenilimidazolidina.
NO20001288L (no) Substituerte 1,2,3,4,5,6-heksahydro-2,6-metano-3-benzazocin- 10-oler, fremgangsmõte for fremstilling derav og anvendelse som legemiddel
NO972449D0 (no) Substituerte 2-arylkarbonyloksymetyl-1,2,5-tiadiazolidin-3-on 1,1 dioksidderivater og preparater og fremgangsmåte for anvendelse derav
NO20010219L (no) Polycykliske tiazolidin-2-ylidenaminer, fremgangsmÕte for deres fremstilling og deres anvendelse som legemiddel
NO960272D0 (no) Oksatiolaner, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder de samme
NO930796D0 (no) Glykopeptidderivater, fremgangsmaate for deres fremstilling og farmasoeytiske midler inneholdende disse
NO953321D0 (no) 2,3 cyklisk kondenserte 1,4-dihydropyridiner, fremgangsmåte for fremstilling derav og deres anvendelse som legemidler
TR199800403A3 (tr) a-Bromo-laktam türevlerinin hazirlanmasi için yöntem.
DK1053224T3 (da) Biphenylfulfonylcyanamider, fremgangsmåde til fremstilling deraf og anvendelse deraf som lægemiddel

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees